702 / 1241
58 pts with recurrent ovarian cancer
Du et al. Eur Rad, 2012
28 PET/CT-IMRT
30 CT-IMRT
Changes in GTV (PETvsCT)
delineation in 10 pts
(35.7%)
inclusion of
metastatic LN and
distant mts
.
Tumor response
: 64.3%
vs. 46.7%
3-year overall survival
:
34.1% vs. 13.2
PET/CT guided IMRT in recurrent ovarian cancer patients improve
the delineation of GTV and reduce the likelihood of geographic
misses and therefore improve the clinical outcome.
PET/CT and RT in Ovarian cancer